Why Your “Ozempic” May Not Be Ozempic: FDA Warnings Highlight Growing Risks of Unregulated GLP-1 Drugs

Why Your “Ozempic” May Not Be Ozempic: FDA Warnings Highlight Growing Risks of Unregulated GLP-1 Drugs

Clinical Trials, Health Policy, Nutrition, Top Stories /

As demand for GLP-1 medications used to treat diabetes and obesity continues to surge, federal health officials are warning consumers that not every product marketed online as “Ozempic” or a […]

Why Your “Ozempic” May Not Be Ozempic: FDA Warnings Highlight Growing Risks of Unregulated GLP-1 Drugs Read More »